Methods
Study design and participants
We did this multicentre, comparative eff ectiveness,
randomised, controlled trial in 30 hospital eye services in
fi ve countries: Australia (one hospital), mainland China
(one), Hong Kong (two), Malaysia (two), Singapore (two),
and the UK (22).
We recruited patients who were phakic, aged 50 years or
older (to limit the eff ect of loss of accommodation
associated with clear-lens extraction), and had newly
diagnosed primary angle closure with intraocular pressure
30 mm Hg or greater or primary angle-closure glaucoma.
Primary angle closure was defi ned as iridotrabecular
contact, either appositional or synechial, of at least 180°
on gonioscopy, and primary angle-closure glaucoma
as reproducible glaucomatous visual fi eld defects,
glaucomatous optic neuropathy, or both, and intraocular
pressure greater than 21 mm Hg on at least one occasion.
Patients with symptomatic cataract, advanced glaucoma
(mean deviation worse than –15 dB or cup-to-disc ratio
≥0·9), or previous acute angle-closure attack or who had
undergone previous laser or ocular surgery were excluded.
An ophthalmologist identifi ed eligible patients and those
informed about the study were noted in a log book. People
willing to participate completed clinical measurements
and study questionnaires at baseline.
The study adhered to the tenets of the Declaration of
Helsinki and was approved by local institutional review
boards. Study participants provided written informed
consent. An independent data monitoring committee
and an independent trial steering committee provided
oversight.
Randomisation and masking
The randomisation schedule was created with a web-based
application at the Centre for Healthcare Randomised Trials,
University of Aberdeen, Aberdeen, UK. The randomisation
algorithm used sex, centre, ethnic origin (Chinese or
non-Chinese), diagnosis, and one or both eyes suitable
for treatment as minimisation covariates.
12
Outcomes
assessors were masked when possible, as described later.
Patients were assigned in equal proportions to treatment
with clear-lens extraction or laser peripheral iridotomy and
topical medical treatment (standard care). Enrolment and
randomisation was done by the local ophthalmologists.
Procedures
Topical medications started at the time of diagnosis were
continued and the interventions were performed within
60 days of randomisation. If both of a patient’s eyes were
suitable for treatment, they were treated in the same way
but data for the eye with more severe disease was used in
the analysis of eye-level outcomes. If only one eye was
suitable for treatment, the other was managed according
to the clinical judgment of the ophthalmologist.
Chia sẻ với bạn bè của bạn: |